A detailed history of Scotia Capital Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Scotia Capital Inc. holds 33,981 shares of BDX stock, worth $7.72 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
33,981
Previous 41,766 18.64%
Holding current value
$7.72 Million
Previous $9.76 Million 16.07%
% of portfolio
0.05%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$221.47 - $242.41 $1.72 Million - $1.89 Million
-7,785 Reduced 18.64%
33,981 $8.19 Million
Q2 2024

Aug 14, 2024

SELL
$225.07 - $246.17 $1.06 Million - $1.16 Million
-4,705 Reduced 10.12%
41,766 $9.76 Million
Q1 2024

May 14, 2024

SELL
$233.45 - $247.73 $6.21 Million - $6.59 Million
-26,589 Reduced 36.39%
46,471 $11.5 Million
Q4 2023

Feb 12, 2024

SELL
$232.24 - $267.23 $1.04 Million - $1.19 Million
-4,465 Reduced 5.76%
73,060 $17.8 Million
Q3 2023

Nov 14, 2023

SELL
$254.9 - $283.59 $6.32 Million - $7.03 Million
-24,791 Reduced 24.23%
77,525 $20 Million
Q2 2023

Aug 03, 2023

SELL
$238.39 - $265.32 $3.28 Million - $3.64 Million
-13,738 Reduced 11.84%
102,316 $27 Million
Q1 2023

May 11, 2023

SELL
$229.71 - $259.35 $1.29 Million - $1.45 Million
-5,599 Reduced 4.6%
116,054 $28.7 Million
Q4 2022

Feb 09, 2023

SELL
$218.29 - $256.91 $595,713 - $701,107
-2,729 Reduced 2.19%
121,653 $30.9 Million
Q3 2022

Nov 10, 2022

SELL
$51.03 - $264.23 $212,233 - $1.1 Million
-4,159 Reduced 3.24%
124,382 $27.7 Million
Q2 2022

Aug 05, 2022

SELL
$234.74 - $275.42 $38,027 - $44,618
-162 Reduced 0.13%
128,541 $31.7 Million
Q1 2022

May 09, 2022

SELL
$243.64 - $270.48 $2.77 Million - $3.08 Million
-11,376 Reduced 8.12%
128,703 $34.2 Million
Q4 2021

Feb 11, 2022

SELL
$230.08 - $250.94 $7.39 Million - $8.06 Million
-32,105 Reduced 18.65%
140,079 $35.2 Million
Q3 2021

Nov 12, 2021

BUY
$232.72 - $256.47 $2.59 Million - $2.86 Million
11,138 Added 6.92%
172,184 $42.3 Million
Q2 2021

Aug 12, 2021

BUY
$232.65 - $254.58 $4.04 Million - $4.42 Million
17,365 Added 12.09%
161,046 $39.2 Million
Q1 2021

May 06, 2021

SELL
$232.09 - $256.88 $3.28 Million - $3.63 Million
-14,148 Reduced 8.96%
143,681 $34.9 Million
Q4 2020

Feb 11, 2021

BUY
$221.92 - $245.94 $5.76 Million - $6.38 Million
25,961 Added 19.69%
157,829 $39.5 Million
Q3 2020

Nov 12, 2020

BUY
$215.77 - $276.76 $28.5 Million - $36.5 Million
131,868 New
131,868 $30.7 Million
Q2 2020

Aug 11, 2020

SELL
$219.9 - $263.41 $23.7 Million - $28.4 Million
-107,880 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$195.69 - $279.01 $2.44 Million - $3.48 Million
12,471 Added 13.07%
107,880 $24.8 Million
Q4 2019

Feb 13, 2020

BUY
$236.45 - $266.82 $1.76 Million - $1.98 Million
7,430 Added 8.45%
95,409 $26 Million
Q3 2019

Nov 14, 2019

BUY
$230.58 - $256.08 $1.78 Million - $1.98 Million
7,713 Added 9.61%
87,979 $22.3 Million
Q2 2019

Aug 13, 2019

BUY
$217.4 - $246.08 $430,234 - $486,992
1,979 Added 2.53%
80,266 $20.2 Million
Q1 2019

May 15, 2019

BUY
$206.05 - $248.17 $1.69 Million - $2.04 Million
8,220 Added 11.73%
78,287 $19.5 Million
Q4 2018

Feb 11, 2019

BUY
$204.73 - $257.93 $818,510 - $1.03 Million
3,998 Added 6.05%
70,067 $15.8 Million
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $3.13 Million - $3.44 Million
13,421 Added 25.49%
66,069 $17.2 Million
Q2 2018

Aug 13, 2018

BUY
$208.1 - $233.85 $109,044 - $122,537
524 Added 1.01%
52,648 $11.3 Million
Q1 2018

May 15, 2018

BUY
$205.46 - $240.27 $2.9 Million - $3.39 Million
14,097 Added 37.07%
52,124 $11.3 Million
Q4 2017

Feb 13, 2018

SELL
$189.0 - $222.64 $106,596 - $125,568
-564 Reduced 1.46%
38,027 $8.14 Million
Q3 2017

Nov 14, 2017

BUY
$186.89 - $198.9 $2.33 Million - $2.48 Million
12,452 Added 47.64%
38,591 $7.56 Million
Q2 2017

Aug 15, 2017

BUY
N/A
26,139
26,139 $5.1 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.8B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Scotia Capital Inc. Portfolio

Follow Scotia Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.